News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,917 Results
Type
Article (29062)
Company Profile (351)
Press Release (458503)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (135695)
Career Advice (422)
Deals (24594)
Drug Delivery (76)
Drug Development (66545)
Employer Resources (66)
FDA (12247)
Job Trends (9948)
News (238148)
Policy (19250)
Tag
Academia (1821)
Academic (1)
Accelerated approval (6)
Adcomms (19)
Allergies (81)
Alliances (37122)
ALS (97)
Alzheimer's disease (1292)
Antibody-drug conjugate (ADC) (158)
Approvals (12292)
Artificial intelligence (274)
Autoimmune disease (29)
Automation (13)
Bankruptcy (177)
Best Places to Work (8466)
BIOSECURE Act (15)
Biosimilars (98)
Biotechnology (262)
Bladder cancer (81)
Brain cancer (31)
Breast cancer (325)
Cancer (2619)
Cardiovascular disease (212)
Career advice (376)
Career pathing (10)
CAR-T (180)
CDC (6)
Cell therapy (493)
Cervical cancer (19)
Clinical research (55181)
Collaboration (989)
Company closure (1)
Compensation (502)
Complete response letters (22)
COVID-19 (2018)
CRISPR (61)
C-suite (307)
Cystic fibrosis (102)
Data (2769)
Denatured (29)
Depression (61)
Diabetes (310)
Diagnostics (4914)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (19)
Drug discovery (128)
Drug pricing (54)
Drug shortages (16)
Duchenne muscular dystrophy (122)
Earnings (51413)
Editorial (27)
Employer branding (12)
Employer resources (60)
Events (82983)
Executive appointments (779)
FDA (13695)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (839)
Gene editing (132)
Generative AI (21)
Gene therapy (382)
GLP-1 (694)
Government (2464)
Grass and pollen (6)
Guidances (142)
Healthcare (12796)
HIV (34)
Huntington's disease (29)
IgA nephropathy (43)
Immunology and inflammation (136)
Immuno-oncology (9)
Indications (36)
Infectious disease (2153)
Inflammatory bowel disease (144)
Inflation Reduction Act (10)
Influenza (47)
Intellectual property (107)
Interviews (51)
IPO (12108)
IRA (21)
Job creations (1934)
Job search strategy (343)
Kidney cancer (12)
Labor market (19)
Layoffs (342)
Leadership (10)
Legal (3245)
Liver cancer (64)
Longevity (11)
Lung cancer (365)
Lymphoma (195)
Machine learning (10)
Management (16)
Manufacturing (328)
MASH (88)
Medical device (9072)
Medtech (9076)
Mergers & acquisitions (13149)
Metabolic disorders (747)
Multiple sclerosis (91)
NASH (17)
Neurodegenerative disease (112)
Neuropsychiatric disorders (33)
Neuroscience (1926)
NextGen: Class of 2025 (3681)
Non-profit (2670)
Now hiring (30)
Obesity (358)
Opinion (150)
Ovarian cancer (94)
Pain (80)
Pancreatic cancer (108)
Parkinson's disease (175)
Partnered (18)
Patents (241)
Patient recruitment (161)
Peanut (46)
People (42724)
Pharmaceutical (68)
Pharmacy benefit managers (6)
Phase I (17593)
Phase II (24287)
Phase III (18275)
Pipeline (1505)
Policy (107)
Postmarket research (1830)
Preclinical (7323)
Press Release (60)
Prostate cancer (132)
Psychedelics (42)
Radiopharmaceuticals (253)
Rare diseases (439)
Real estate (3669)
Recruiting (27)
Regulatory (15589)
Reports (26)
Research institute (1850)
Resumes & cover letters (46)
Rett syndrome (10)
RNA editing (10)
RSV (30)
Schizophrenia (86)
Series A (152)
Series B (98)
Service/supplier (6)
Sickle cell disease (64)
Special edition (15)
Spinal muscular atrophy (139)
Sponsored (29)
Startups (2684)
State (1)
Stomach cancer (11)
Supply chain (61)
Tariffs (27)
The Weekly (48)
Vaccines (588)
Venture capital (44)
Weight loss (209)
Women's health (35)
Worklife (3)
Date
Today (79)
Last 7 days (350)
Last 30 days (1652)
Last 365 days (27075)
2025 (14672)
2024 (30157)
2023 (33607)
2022 (43710)
2021 (46640)
2020 (42593)
2019 (32186)
2018 (24094)
2017 (24507)
2016 (22908)
2015 (26833)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (440)
Alabama (57)
Alaska (4)
Arizona (124)
Arkansas (11)
Asia (31175)
Australia (5397)
California (6367)
Canada (1928)
China (660)
Colorado (270)
Connecticut (252)
Delaware (176)
Europe (70351)
Florida (872)
Georgia (225)
Hawaii (2)
Idaho (35)
Illinois (475)
India (28)
Indiana (314)
Iowa (12)
Japan (222)
Kansas (88)
Kentucky (14)
Louisiana (8)
Maine (37)
Maryland (815)
Massachusetts (5049)
Michigan (232)
Minnesota (326)
Mississippi (3)
Missouri (71)
Montana (27)
Nebraska (12)
Nevada (56)
New Hampshire (55)
New Jersey (1852)
New Mexico (25)
New York (1760)
North Carolina (909)
North Dakota (9)
Northern California (2797)
Ohio (185)
Oklahoma (15)
Oregon (28)
Pennsylvania (1335)
Puerto Rico (15)
Rhode Island (28)
South America (635)
South Carolina (10)
Southern California (2395)
Tennessee (84)
Texas (847)
United States (23267)
Utah (135)
Virginia (158)
Washington D.C. (58)
Washington State (540)
West Virginia (2)
Wisconsin (53)
487,917 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Phase III
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial
Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a chronic blood cancer taking the drug didn’t need to have their blood removed to bring down dangerously high hemocrit levels.
March 3, 2025
·
2 min read
·
Annalee Armstrong
Alzheimer’s disease
FDA Clears First Alzheimer’s Blood Test, Lending ‘Momentum’ to Lilly’s Kisunla, Biogen’s Leqembi
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s disease therapies.
May 19, 2025
·
2 min read
·
Tristan Manalac
Press Releases
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
May 22, 2025
·
1 min read
Press Releases
Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
May 30, 2025
·
3 min read
Press Releases
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025
May 21, 2025
·
2 min read
Press Releases
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
May 28, 2025
·
1 min read
Press Releases
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
June 9, 2025
·
1 min read
Press Releases
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
June 2, 2025
·
1 min read
Press Releases
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
May 29, 2025
·
2 min read
Press Releases
Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference
May 12, 2025
·
1 min read
1 of 48,792
Next
